COMMUNIQUÉS West-GlobeNewswire

PEMF Therapy Emerges as a Leading 2025 Wellness Trend for Drug-Free Pain Relief; Grooni Earthing’s Pro Collection Meets Rising Demand
26/08/2025
SHERIDAN, WY , Aug. 26, 2025 (GLOBE NEWSWIRE) -- As consumers seek science-informed, non-pharmacological options for chronic pain and recovery, pulsed electromagnetic field (PEMF) therapy is gaining momentum. Market [...]
KFSHRC Saves Saudi 7-Year-Old Through Cross-Border Heart Transplant with UAE Donor
26/08/2025
RIYADH, Saudi Arabia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed a life-saving heart transplant on a 7-year-old Saudi child using [...]
Tevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company’s Mission of Health Equity
26/08/2025
WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today expressed its appreciation to Yale University for recognizing Founder and CEO Dr. Ryan Saadi, MPH [...]
Plus de 2 000 opérations chirurgicales effectuées avec succès dans des cas d’épilepsie pharmaco-résistante
26/08/2025
KFSHRC réalise une avancée majeure dans le traitement de l’épilepsie grâce à la SEEG RIYAD, Arabie saoudite, 26 août 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) a renforcé [...]
BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025
26/08/2025
Company to host conference call at 8 a.m. ET, August 27, 2025 NEW HAVEN, Conn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence [...]
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
26/08/2025
NEWTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for [...]
Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
26/08/2025
PURCHASE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, was [...]
University of St. Augustine for Health Sciences Sponsors U.S. Open Adaptive Surfing Championships for Fifth Consecutive Year
26/08/2025
The University’s Occupational Therapy and Physical Therapy students, along with alumni, will provide vital hands-on athlete support at the event OCEANSIDE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The University of St [...]
PCI Biotech: Invitation to first half 2025 results presentation and corporate update
26/08/2025
Oslo, Norway, 26 August 2025 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2025 interim report on Friday, 29 August 2025, 08:30am – 09:00am CET (local time). The presentation [...]
Trethera Awarded $2.3 Million NIH Grant to Study TRE-515 Combined with Radiation Therapy in Prostate Cancer Preclinical Models
26/08/2025
LOS ANGELES, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today the [...]
Becker’s Healthcare Names U.S. Oral Surgery Management to 2025 DSOs to Know List
26/08/2025
IRVING, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) -- For the second year in a row, Becker’s Healthcare has named U.S. Oral Surgery Management ( USOSM ) to this year’s DSOs to Know list. Honorees are selected by Becker’s, [...]
Marker Therapeutics Provides Update on Phase 1 APOLLO Study Highlighting Encouraging Overall Response Rates in Relapsed Lymphoma
26/08/2025
Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphoma showed 66% of Non-Hodgkin Lymphoma (NHL) patients achieving objective response rates, with 50% demonstrating complete response [...]
Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
26/08/2025
Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug. 26, 2025 (GLOBE NEWSWIRE [...]
Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference
26/08/2025
MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 4:50 [...]
Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
26/08/2025
WALTHAM, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Kraig Biocraft Laboratories Accelerates Operations into Two Rearing Centers in One of Southeast Asia's Premier Silk-Producing Regions
26/08/2025
ANN ARBOR, Mich., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that its two recently [...]
The Save Mart Companies Honored for Transforming Workers’ Comp Program in Collaboration with CorVel
26/08/2025
FORT WORTH, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, congratulates its partner, The Save Mart Companies , one of the West Coast's [...]
Zevra Therapeutics to Participate at Upcoming Investor Conferences in September
26/08/2025
CELEBRATION, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, [...]
Plus Therapeutics Regains Compliance with Applicable Nasdaq Listing Criteria
26/08/2025
No near-term Reverse Stock Split required to meet Bid Price Rule HOUSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) , a clinical-stage pharmaceutical company developing [...]

Pages